register

News & Trends - MedTech & Diagnostics

New J&J cervical spine system to reduce procedural complexity and surgical costs

Health Industry Hub | November 25, 2019 |

The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes has launched the SYMPHONY Occipito-Cervico-Thoracic (OCT) System, expanding its offering for the surgical treatment of conditions in the neck and upper back.

The SYMPHONY System includes a differentiated offering of instruments and implants designed for stabilisation of the spine in patients undergoing Posterior Cervical Fusion surgery. The announcement was made at the 47th annual Cervical Spine Research Society (CSRS) meeting.

Guided by research conducted in association with the International Spine Study Group, the SYMPHONY System is designed to improve surgeon experience in four key areas: fixation, alignment, targeting and extensions. The range of instrumentation offers options for surgeons to choose from and is compatible with navigation software to aid in targeting in challenging anatomy.

“The most interesting aspect of the SYMPHONY System is its ability to address highly complex needs that we face at the front lines of cervical spine surgery,” said Dr Christopher Ames, Spine Surgeon. “It also takes into account ways to create efficiencies for healthcare systems, making it a truly comprehensive offering.”

The SYMPHONY System was designed to improve fixation in patients with suboptimal bone quality, to address a potential cause of screw failure which may lead to revision surgery. By enabling crossing of the cervical to thoracic junction with one system, the SYMPHONY System reduces the number of instrument trays from six to two, which may provide cost savings in processing and sterilisation as well.1

The system combines the benefits of two market-leading posterior cervical systems—the SYNAPSE OCT System and MOUNTAINEER OCT System—uniting many of the patented features of those brands and building on their proven instrumentation.

You may also like QLD researchers discover blood test for deadly ocular melanoma

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Digital & Innovation

Cybersecurity tops investment priorities for ANZ companies

Cybersecurity tops investment priorities for ANZ companies

Health Industry Hub | September 17, 2024 |

Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% […]

More


News & Trends - Pharmaceuticals

Novo Nordisk and Lilly's GLP-1 agonists show promise in type 1 diabetes

Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes

Health Industry Hub | September 17, 2024 |

Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]

More


News & Trends - MedTech & Diagnostics

Health Department’s proposed reporting rules face industry pushback over costs and confidentiality

Health Department’s proposed reporting rules face industry pushback over costs and confidentiality

Health Industry Hub | September 17, 2024 |

MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]

More


News & Trends - MedTech & Diagnostics

Threat to innovation: Health Department’s PL reforms spark industry backlash

Threat to innovation: Health Department’s PL reforms spark industry backlash

Health Industry Hub | September 17, 2024 |

MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]

More


This content is copyright protected. Please subscribe to gain access.